# reload+after+2024-01-23 01:44:07.595987
address1§Building 7
address2§Kiryat Atidim
city§Tel Aviv
zip§6158002
country§Israel
phone§972 77 331 0156
website§https://www.chemomab.com
industry§Biotechnology
sector§Healthcare
longBusinessSummary§Chemomab Therapeutics Ltd., a clinical-stage biotechnology company, discovers and develops therapeutics for the treatment of fibrotic and inflammatory diseases. The company's lead clinical product candidate is CM-101, a humanized monoclonal antibody had completed Phase 2a clinical trials that hinders the basic function of soluble chemokine CCL24 for the treatment of primary sclerosing cholangitis (PSC) and systemic sclerosis (SSc). The company was formerly known as Anchiano Therapeutics Ltd. and changed its name to Chemomab Therapeutics Ltd. in March 2021. Chemomab Therapeutics Ltd. was founded in 2011 and is based in Tel Aviv, Israel.
companyOfficers§[{'maxAge': 1, 'name': 'Dr. Adi Mor George Ph.D.', 'age': 41, 'title': 'Co-Founder, Chief Scientific Officer, CEO & Executive Director', 'yearBorn': 1982, 'fiscalYear': 2022, 'totalPay': 435396, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Sigal  Fattal', 'age': 52, 'title': 'Chief Financial Officer', 'yearBorn': 1971, 'fiscalYear': 2022, 'totalPay': 258000, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Barbara  Lindheim', 'title': 'Consulting Vice President of Investor & Public Relations, Strategic Communications', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Matthew B. Frankel M.B.A., M.D.', 'age': 54, 'title': 'Chief Medical Officer & VP of Drug Development', 'yearBorn': 1969, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}]
compensationAsOfEpochDate§1672444800
maxAge§86400
priceHint§4
payoutRatio§0.0
beta§-0.261
currency§USD
dateShortInterest§1702598400
forwardEps§-0.09
exchange§NCM
quoteType§EQUITY
shortName§Chemomab Therapeutics Ltd.
longName§Chemomab Therapeutics Ltd.
firstTradeDateEpochUtc§1549981800
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§f2fd6842-2d35-37be-bf48-b334c1a2bb54
gmtOffSetMilliseconds§-18000000
targetHighPrice§7.0
targetLowPrice§7.0
targetMeanPrice§7.0
targetMedianPrice§7.0
recommendationMean§2.5
recommendationKey§buy
numberOfAnalystOpinions§1
quickRatio§4.152
grossMargins§0.0
ebitdaMargins§0.0
trailingPegRatio§None
